Andere Sprachen ANGLE plc

Aktien

A0B7QK

GB0034330679

AGL

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:01 24.04.2024			% 5 Tage	% 1. Jan.
15.5 ^GBX	+26.53%		+26.53%	+31.91%

18:08	Kein Rekordschluss für den FTSE 100; gemischter Handel in den USA	AN
18:02	Kein Rekordschluss für den FTSE 100; gemischter Handel in den USA	AN

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

No record close for FTSE 100; mixed trade in US	18:08
No record close for FTSE 100; mixed trade in US	18:02
ANGLE partners with AstraZeneca in groundbreaking oncology contract	16:54
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	16:14
Angle shares jump on supplier agreement with with AstraZeneca	11:34
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook	11:12
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	08:00
ANGLE PLC - US AND EU PATENTS FOR ANGLE'S INNOVATIVE CELLKEEP SLIDE	23.04.
ANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow	23.04.
Angle granted patents in US and Europe for Cellkeep slide	22.04.
Angle plc Secures European Patent for CellKeep Technology	22.04.
ANGLE PLC - PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE	09.04.
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	08.04.
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	25.03.
ANGLE PLC - PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE	25.03.
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	23.01.
Angle highlights supportive data for DNA analysis tool	22.01.
ANGLE PLC - BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER	05.01.
Stocks up ahead of US nonfarm payrolls	04.01.
Angle shares soar following "breakthrough" cancer diagnostics results	04.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ANGLE plc

Aktien

A0B7QK

GB0034330679

AGL

Andere Sprachen

Filter